Clinical Trials Browser

Phase 2 × Interventional × Gastric Cancer Adenocarcinoma Metastatic × Clear all

NCT07392346 2026-02-11

Safety and Efficacy of Fruquintinib Plus Nab-Paclitaxel and Iparomlimab and Tuvonralimab Injection in the Second-Line Treatment for Immunotherapy-experienced Advanced Gastric Cancer

Phase 2 Recruiting

Gastrointestinal

Gastric Cancer Adenocarcinoma Metastatic

NCT06962137 2025-12-22

RAINSPOT

Phase 2 Recruiting

Gastrointestinal

Gastric Cancer Adenocarcinoma Metastatic

NCT06711471 2024-12-02

Trifluridine/tipiracil (TAS-102), Bevacizumab, and Camrelizumab As Third-line or Later-line Therapy of Gastric Cancer

Phase 2 Recruiting

Gastrointestinal

Gastric Cancer Adenocarcinoma Metastatic

NCT00517829 2016-11-28

Docetaxel+Oxali+/-Cetux Met Gastric/GEJ

Phase 2 Completed

150 enrolled 12 charts

Gastrointestinal

Gastric Cancer Adenocarcinoma Metastatic